Intra-Cellular Therapies (ITCI.MX) Q2 2024 Earnings

7MayConfirmed
Q3 2023
Q4 2023
Q1 2024
Q2 2024
-10.22
-7.71
-5.21
-2.7

Details

Expected EPS
-5.3635644936
Actual EPS
-2.7036480000000003
Surprise EPS
2.66
Surprise Percent
+49.59%

Description

Intra-Cellular Therapies (ITCI.MX) has reported earnings of -2.7036480000000003 per share for Q2 2024.

0 Comments

Share your thoughts